公开发售 Archives - 第7页共12页 - Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering

By Sichenzia Ross Ference LLP | 6 5 月, 2020

CEL-SCI Corporation

$5,000,000

Registered Direct Offering of Common Stock

Private Placement of Warrants

Represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as Exclusive Placement Agent

August 2016

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering

By Sichenzia Ross Ference LLP | 6 5 月, 2020

EyeGate Pharmaceuticals, Inc.

$3,770,000

Registered Direct Offering of Common Stock and Preferred Stock

Private Placement of Warrants

Represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as Exclusive Placement Agent

July 2016

Sichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering

By Sichenzia Ross Ference LLP | 6 5 月, 2020

Vuzix Corporation

$6,600,000

Registered Direct Offering of Common Stock

July 2016

Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock

By Sichenzia Ross Ference LLP | 6 5 月, 2020

Tonix Pharmaceuticals Holding Corp.

$10,000,000

Public Offering

Common Stock

June 2016

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.

By Sichenzia Ross Ference LLP | 6 5 月, 2020

Intellicheck Mobilisa, Inc.

$2,100,000

Public Offering

Common Stock and Warrants

Represented Joseph Gunnar & Co. LLC as Sole Book-Running Manager

June 2016

Partners Richard A. Friedman and Stephen A. Cohen Represent Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book Running Managers of PhaseRx, Inc.’s $18.5M IPO

By Sichenzia Ross Ference LLP | 6 5 月, 2020

PhaseRx, Inc.

$18,500,000

Initial Public Offering

Common Stock

Represented Laidlaw & Company (UK) Ltd. and Roth Capital Partners, LLC as Joint Book-Running Managers

May 2016

Sichenzia Ross Friedman Ference LLP Represents Axiom Capital Management, Inc. In $1.2 Million Public Offering of iSign Solutions Inc.

By Sichenzia Ross Ference LLP | 6 5 月, 2020

iSign Solutions Inc.

$1,200,000

Public Offering

Common Stock and Warrants

Represented Axiom Capital Management, Inc. as Representative of the Underwriters

May 2016

Sichenzia Ross Friedman Ference LLP Represents DelMar Pharmaceuticals, Inc. in $5.6 Million Sale of Series B Preferred Shares

By Sichenzia Ross Ference LLP | 6 5 月, 2020

DelMar Pharmaceuticals

$5,600,000

Private Placement of Series B Preferred Stock

May 2016

Sichenzia Ross Friedman Ference LLP Represents H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC as Joint Book Running Managers for $6.0 Public Offering and Uplisting to Nasdaq

By Sichenzia Ross Ference LLP | 6 5 月, 2020

Labstyle Innovations Corp.

$6,000,000

Public Offering

Common Stock and Warrants

Represented H.C. Wainwright & Co., LLC and Joseph Gunnar & Co. as Joint Book Running Managers

March 2016

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in a $3 Million Registered Direct Offering

By Sichenzia Ross Ference LLP | 6 5 月, 2020

Amarantus BioScience Holdings, Inc.

$3,000,000

Convertible Preferred Stock and Warrants

February 2016

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.